Dr. Eva Isabelle Beaulieu, MD

Dr. Beaulieu practices at Swift Health Medical Group - Morrow in Morrow, Georgia.

Dr. Beaulieu's NPI, 1366603557, was assigned on June 19, 2008. Dr. Beaulieu graduated from Ross University School of Medicine in 2008. Dr. Beaulieu holds Georgia license 066254.

Dr. Beaulieu's primary practice is Swift Health Medical Group - Morrow, at 6053 Jonesboro Rd, Morrow, GA 30260. The practice phone is (770) 824-4343.

Dr. Beaulieu's primary practice is Swift Health Medical Group - Morrow in Morrow, Georgia. Dr. Beaulieu is also affiliated with Atrium Health Navicent The Medical Center. The medical group on file is Swift Health Medical Group. Dmand AI also links Dr. Beaulieu to 4 more hospitals, 7 medical groups and 2 group practices and clinics, each named with a free account. Dr. Beaulieu's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beaulieu practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Beaulieu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Beaulieu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Beaulieu's licenses on file in 2 states: Georgia and Texas.

Dmand AI lists anemia, chronic anemia, chronic hypertension, congestive heart failure, coronary artery disease, electrolyte disorders, gastrointestinal bleeding and headaches among the conditions Dr. Beaulieu treats.

CMS data shows 390 Medicare services from Dr. Beaulieu across 4 procedure codes in 2024, for 263 Medicare patients. Medicare paid $44,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 263 Medicare patients who saw Dr. Beaulieu in 2024. The largest group is 75 to 84, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beaulieu's median patient age at 62, with 55% women.

In 2024, Dr. Beaulieu wrote 672 Medicare Part D claims for 133 patients. 85% of them were for generic drugs. CMS names the drug for 296 of them, across 16 drugs with 11 or more claims each, at $13,036 in total drug cost. In 2023, CMS named 101 claims across 6 drugs.

Dr. Beaulieu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Beaulieu to 8 clinical trials, 3 of them phase 3 studies. Conditions studied include Colitis, Ulcerative, Rectal Diseases and Colitis. Shire sponsors the most, 5.

CMS Open Payments shows 9 general payments to Dr. Beaulieu from 8 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $102.

Dr. Beaulieu graduated from Ross University School of Medicine in 2008.

Dr. Beaulieu is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.